Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

Lancet Infectious Diseases

Volumn 7, Issue 7, 2007, Pages 453-459

  de Sanjosé, Silvia ^a   Diaz, Mireia ^a   Castellsagué, Xavier ^a   Clifford, Gary ^b   Bruni, Laia ^a   Muñoz, Nubia ^a   Bosch, F Xavier ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

AFRICA; AGE DISTRIBUTION; ASIA; CENTRAL AMERICA; CONFIDENCE INTERVAL; DNA DETERMINATION; EUROPE; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MEXICO; NORTH AMERICA; PREVALENCE; PRIORITY JOURNAL; REVIEW; SAMPLING; SYSTEMATIC REVIEW; UTERINE CERVIX CYTOLOGY; VIRUS CARRIER; VIRUS DETECTION; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

ADULT; AGE FACTORS; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; WORLD HEALTH;

EID: 34250736244     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(07)70158-5     Document Type: Review

References (23)

1. Bosch F., Lorincz A., Muñoz N., Meijer C., and Shah K. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55 (2002) 244-265
2. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2 (2002) 342-350
3. Walboomers J., Jacobs M., Manos M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
4. Ferlay J., Bray F., Pisani P., and Parkin D. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase. 2.0 edn. (2004), IARC Press, Lyon
5. Parkin D. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118 (2006) 3030-3044
6. Clifford G., Gallus S., Herrero R., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 (2005) 991-998
7. Ishi K., Suzuki F., Yamasaki S., et al. Prevalence of human papillomavirus infection and correlation with cervical lesions in Japanese women. J Obstet Gynaecol Res 30 (2004) 380-385
8. Bohning D., Dietz E., and Schlattmann P. Recent developments in computer-assisted analysis of mixtures. Biometrics 54 (1998) 525-536
9. Bayo S., Bosch F., de Sanjose S., et al. Risk factors of invasive cervical cancer in Mali. Int J Epidemiol 31 (2002) 202-209
10. Parkin D., Whelan S., Ferlay J., Teppo L., and Thomas D. Cancer incidence in five continents. Volume VIII. IARC Scientific Publications number 155 (2002), International Agency for Research on Cancer, Lyon, France
11. Li L., Dai M., Clifford G., et al. Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study. Br J Cancer 95 (2006) 1593-1637
12. Liu J., Rose B., Huang X., et al. Comparative analysis of characteristics of women with cervical cancer in high- versus low-incidence regions. Gynecol Oncol 94 (2004) 803-810
13. Anon. UNAIDS: global AIDS epidemic just beginning. AIDS Policy Law 20 (2005) 1
14. Sankaranarayanan R., Chatterji R., Shastri S., et al. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India. Int J Cancer 112 (2004) 341-347
15. Franceschi S., Herrero R., Clifford G., et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 119 (2006) 2677-2684
16. Franceschi S., Rajkumar R., Snijders P., et al. Papillomavirus infection in rural women in southern India. Br J Cancer 92 (2005) 601-606
17. Alexandrova Y., Lyshchov A., Safronnikova N., Imyanitov E., and Hanson K. Features of HPV infection among the healthy attendants of gynecological practice in St Petersburg, Russia. Cancer Lett 145 (1999) 43-48
18. Chan P., Cheung T., Tam A., et al. Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers. Int J Cancer 118 (2006) 243-245
19. Clifford G., Smith J., Aguado T., and Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 89 (2003) 101-105
20. Muñoz N., Bosch F., de Sanjose S., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
21. Castellsague X., Diaz M., de Sanjose S., et al. The worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 198 (2006) 303-315
22. Khan M., Castle P., Lorincz A., et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 97 (2005) 1072-1079
23. Bosch F., and de Sanjose S. Chapter 1: human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 31 (2003) 3-13